{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:57:58Z","timestamp":1761631078499,"version":"3.40.5"},"reference-count":9,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0417","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:16:05Z","timestamp":1738361765000},"page":"637-643","source":"Crossref","is-referenced-by-count":2,"title":["Association between serum thyroglobulin levels and glycemic control in patients with thyroid cancer after radioiodine therapy"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4710-6393","authenticated-orcid":false,"given":"Yuji","family":"Hataya","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1520-7771","authenticated-orcid":false,"given":"Yuko","family":"Fujishima","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-4055","authenticated-orcid":false,"given":"Kanta","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Iwakura","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3076-1487","authenticated-orcid":false,"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26: 1\u2013133.","DOI":"10.1089\/thy.2015.0020"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Hataya Y, Nomura T, Fujishima Y, Fujimoto K, Iwakura T, et al. (2024) Correlation between glycemic control and serum thyroglobulin levels in a patient with RAI-refractory thyroid cancer. JCEM Case Rep 2: luae085.","DOI":"10.1210\/jcemcr\/luae085"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Ito Y, Onoda N, Kihara M, Miya A, Miyauchi A (2021) Prognostic significance of neutrophil-to-lymphocyte ratio in differentiated thyroid carcinoma having distant metastasis: a comparison with thyroglobulin-doubling rate and tumor volume-doubling rate. In Vivo 35: 1125\u20131132.","DOI":"10.21873\/invivo.12358"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Chung S, Lee Y, Roh EY (2019) HbA1c showed a positive association with carcinoembryonic antigen (CEA) level in only diabetes, not prediabetic or normal individuals. J Clin Lab Anal 33: e22900.","DOI":"10.1002\/jcla.22900"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Murai J, Soga S, Saito H, Otsuki M, Kitada T, et al. (2013) Study on the mechanism causing elevation of serum CA19-9 levels in diabetic patients. Endocr J 60: 885\u2013891.","DOI":"10.1507\/endocrj.EJ12-0364"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kitahara CM, McCullough ML, Franceschi S, Rinaldi S, Wolk A, et al. (2016) Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies. Thyroid 26: 306\u2013318.","DOI":"10.1089\/thy.2015.0319"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Zhao J, Zhang Q, Yang Y, Yao J, Liao L, et al. (2021) High prevalence of thyroid carcinoma in patients with insulin resistance: a meta-analysis of case-control studies. Aging (Albany NY) 13: 22232\u201322241.","DOI":"10.18632\/aging.203529"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Caetano C, Pico PT, Singh C, Tendler B, Malchoff DM, et al. (2022) Metformin decreases serum thyroglobulin concentration in nonmedullary thyroid carcinoma. J Endocr Soc 6: bvac140.","DOI":"10.1210\/jendso\/bvac140"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kozal K, J\u00f3\u017awiak P, Krze\u015blak A (2021) Contemporary perspectives on the Warburg effect inhibition in cancer therapy. Cancer Control 28: 10732748211041243.","DOI":"10.1177\/10732748211041243"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/5\/72_EJ24-0417\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:31:46Z","timestamp":1746847906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/5\/72_EJ24-0417\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0417","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"type":"print","value":"0918-8959"},{"type":"electronic","value":"1348-4540"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0417"}}